Humanwell Healthcare Group Co

Humanwell Healthcare Group Co EBIT per Share

The EBIT per Share of Humanwell Healthcare Group Co (600079.SS) as of Oct 31, 2026 is 2.34 CNY. In the previous year, EBIT per Share was 1.55 CNY — a change of 51.40% (higher).

EBIT per Share

2.34CNY

YoY

51.40%

Last updated:

EBIT per Share of Humanwell Healthcare Group Co is 2025 2.34 CNY. EBIT per Share of Humanwell Healthcare Group Co was 2024 1.55 CNY. It decreases by 51.40% higher compared to the previous year.

The Humanwell Healthcare Group Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
1.41 CNY
Jan 1, 2022
2.18 CNY
Jan 1, 2023
2.07 CNY
Jan 1, 2024
1.55 CNY
Jan 1, 2025
2.34 CNY
Jan 1, 2026 (e)
2.55 CNY
Jan 1, 2027 (e)
2.84 CNY
Jan 1, 2028 (e)
2.77 CNY
The Humanwell Healthcare Group Co EBIT per Share history
YEAREBIT per ShareYoY
est2.77CNY-2.52%
est2.84CNY+11.28%
est2.55CNY+8.86%
2.34CNY+51.40%
1.55CNY-25.35%
2.07CNY-4.74%
2.18CNY+54.73%
1.41CNY-7.35%
1.52CNY+16.39%
1.30CNY+18.20%
1.10CNY-52.51%
2.32CNY+126.73%
1.03CNY+47.16%
0.70CNY-8.67%
0.76CNY+6.19%
0.72CNY+1.22%
0.71CNY+24.67%
0.57CNY+40.24%
0.41CNY+80.47%
0.22CNY+76.85%
0.13CNY+40.31%
0.09CNY-41.01%
0.15CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

EBIT per Share of Humanwell Healthcare Group Co is 2.34 CNY in 2025.

EBIT per Share of Humanwell Healthcare Group Co changed from 1.55 CNY to 2.34 CNY, representing a 51.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Humanwell Healthcare Group Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Humanwell Healthcare Group Co